Arcutis Biotherapeutics, Inc. ARQT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s operating lease ROU assets?
- Arcutis Biotherapeutics, Inc. (ARQT) reported operating lease ROU assets of $4.36M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s operating lease ROU assets increased by 136.8% year-over-year, from $1.84M to $4.36M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s operating lease ROU assets has grown at a 3539.0% compound annual growth rate (CAGR), from $0.07 to $4.47M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.